Dr Mohammad Khan earned his Master's and PhD degrees in 1995 and 2001, respectively, from the Aligarh Muslim University, India. He has previously served as a junior faculty member in the Department of Neurology at the Medical College of Georgia at Augusta University, USA, and is currently affiliated with the Department of Biochemistry and Molecular Biology at the University of Zawia, Libya.
His research is focused on improving cognition and neurological outcomes of neuropsychiatric/neurological disorders in model animals and human subjects with mental disabilities including schizophrenia. He is currently focusing on antipsychotic drugs, estrogens, and various estrogen receptor modulators/agonists, and combines clinical and basic research methodologies to find effective therapies for patients with mental disabilities.
Mohammad has published numerous research papers and reviews in high impact journals, and has also published two book chapters, including 'Phospholipid spectrum disorders in psychiatry and neurology' for Marius Press. He has been a member of various professional societies including the Society for Neuroscience, the Society of Biological Psychiatry and the International Brain Research Organization. He was also the recipient of the Young Investigator Award at the International Congress on Schizophrenia Research (ICOSR-2005) held in Texas, USA.